Page 23 - TD-1-1

Tumor Discovery Monocytes from single-cell analysis

therapeutic strategy against hepatocellular carcinoma. Gut, 43. Lee J, Breton G, Oliveira TY, et al., 2015, Restricted dendritic
66(1): 157–167. cell and monocyte progenitors in human cord blood and
bone marrow. J Exp Med, 212(3): 385–399.
https://doi.org/10.1136/gutjnl-2015-310514
33. Gordon IO, Freedman RS, 2006, Defective antitumor https://doi.org/10.1084/jem.20141442
function of monocyte-derived macrophages from epithelial 44. Menezes S, Melandri D, Anselmi G, et al., 2016, The
ovarian cancer patients. Clin Cancer Res, 12(5): 1515–1524. heterogeneity of Ly6C monocytes controls their
https://doi.org/10.1158/1078-0432.CCR-05-2254 differentiation into iNOS macrophages or monocyte-
derived dendritic cells. Immunity, 45(6): 1205–1218.
34. Sheng J, Chen Q, Soncin I, et al., 2017, A discrete subset of
monocyte-derived cells among typical conventional Type 2 https://doi.org/10.1016/j.immuni.2016.12.001
dendritic cells can efficiently cross-present. Cell Rep, 21(5): 45. Gabrilovich DI, Bronte V, Chen SH, et al., 2007, The
1203–1214. terminology issue for myeloid–derived suppressor cells.
https://doi.org/10.1016/j.celrep.2017.10.024 Cancer Res, 67(1): 425; author reply 426.
35. Hanna RN, Cekic C, Sag D, et al., 2015, Patrolling monocytes https://doi.org/10.1158/0008-5472.CAN-06-3037
control tumor metastasis to the lung. Science (New York), 46. Veglia F, Perego M, Gabrilovich D, 2018, Myeloid-derived
350(6263): 985–990. suppressor cells coming of age. Nat Immunol, 19(2): 108–119.
https://doi.org/10.1126/science.aac9407 https://doi.org/10.1038/s41590-017-0022-x
36. Romano E, Kusio-Kobialka M, Foukas PG, et al., 2015, 47. Filipazzi P, Valenti R, Huber V, et al., 2007, Identification of
Ipilimumab-dependent cell-mediated cytotoxicity of a new subset of myeloid suppressor cells in peripheral blood
regulatory T cells ex vivo by nonclassical monocytes in of melanoma patients with modulation by a granulocyte-
melanoma patients. Proc Natl Acad Sci U S A, 112(19): macrophage colony-stimulation factor-based antitumor
6140–6145. vaccine. J Clin Oncol, 25(18): 2546–2553.
https://doi.org/10.1073/pnas.1417320112 https://doi.org/10.1200/JCO.2006.08.5829
37. De Palma M, Venneri MA, Galli R, et al., 2005, Tie2 48. Zea AH, Rodriguez PC, Atkins MB, et al., 2005, Arginase-
identifies a hematopoietic lineage of proangiogenic producing myeloid suppressor cells in renal cell carcinoma
monocytes required for tumor vessel formation and a patients: A mechanism of tumor evasion. Cancer Res, 65(8):
mesenchymal population of pericyte progenitors. Cancer 3044–3048.
Cell, 8(3): 211–226.
https://doi.org/10.1158/0008-5472.CAN-04-4505
https://doi.org/10.1016/j.ccr.2005.08.002
49. Srivastava MK, Bosch JJ, Thompson JA, et al., 2008, Lung
38. Venneri MA, De Palma M, Ponzoni M, et al., 2007, cancer patients’ CD4(+) T cells are activated in vitro by
Identification of proangiogenic TIE2–expressing monocytes MHC II cell-based vaccines despite the presence of myeloid-
(TEMs) in human peripheral blood and cancer. Blood, derived suppressor cells. Cancer Immunol Immunother,
109(12): 5276–5285. 57(10): 1493–1504.
https://doi.org/10.1182/blood-2006-10-053504 https://doi.org/10.1007/s00262-008-0490-9
39. Duan Z, Luo Y, 2021, Targeting macrophages in cancer 50. Hoechst B, Ormandy LA, Ballmaier M, et al., 2008, A
immunotherapy. Signal Transduct Target Ther, 6(1): 127. new population of myeloid-derived suppressor cells in
https://doi.org/10.1038/s41392-021-00506-6 hepatocellular carcinoma patients induces CD4(+)CD25(+)
Foxp3(+) T cells. Gastroenterology, 135(1): 234–243.
40. Wynn TA, Chawla A, Pollard JW, 2013, Macrophage
biology in development, homeostasis and disease. Nature, https://doi.org/10.1053/j.gastro.2008.03.020
496(7446): 445–455. 51. Canè S, Ugel S, Trovato R, et al., 2019, The endless saga of
https://doi.org/10.1038/nature12034 monocyte diversity. Front Immunol, 10: 1786.
41. Ginhoux F, Jung S, 2014, Monocytes and macrophages: https://doi.org/10.3389/fimmu.2019.01786
developmental pathways and tissue homeostasis. Nat Rev 52. Cassetta L, Bruderek K, Skrzeczynska-Moncznik J, et al.,
Immunol, 14(6): 392–404. 2020, Differential expansion of circulating human MDSC
https://doi.org/10.1038/nri3671 subsets in patients with cancer, infection and inflammation.
J Immunother Cancer, 8(2): e001223.
42. Fogg DK, Sibon C, Miled C, et al., 2006, A clonogenic bone
marrow progenitor specific for macrophages and dendritic https://doi.org/10.1136/jitc-2020-001223
cells. Science (New York), 311(5757): 83–87.
53. Hartwig T, Montinaro A, von Karstedt S, et al., 2017, The
https://doi.org/10.1126/science.1117729 TRAIL-induced cancer secretome promotes a tumor-

Volume 1 Issue 1 (2022) 14 https://doi.org/10.36922/td.v1i1.4